Member: vacantAlternate: Elisa…
Member: vacantAlternate: Elisa SulleiroAgencia Española del Medicamento y Productos SanitariosParque Empresarial Las MercedesEdificio 8C/Campezo 1ES-28022 MADRID
Member: Stavroula…
Member: Stavroula MamouchaAlternate: Eleni Katsomiti National Organization for MedicinesRegistration DivisionMesogion Avenue 284HolargosGR-15562 ATHENS
CMDH PRESS RELEASES 2025
Report from the meeting held on 28-29 January 2025
Pamorelin LA 22.5 mg (triptorelin…
Pamorelin LA 22.5 mg (triptorelin pamoate)End of procedure: 04/12/2024Date of publication: 06/02/2025
Member: Natasa KizaAlternate:…
Member: Natasa KizaAlternate: Maria Eleni Avraamidou Ministry of HealthPharmaceutical Services7 Larnacos AvenueCY-1475 NICOSIA
Updated eAF 1.27.0.0 Human Variation form
Human Variation eAF form - parallel procedures section (further variation regulation update)
Meeting 28-30 January 2025:…
Meeting 28-30 January 2025: Agenda
The ICH E6(R3) Introductory Training Presentation is now available on the ICH website
Following the adoption of the E6(R3) Guideline on 6 January 2025, a Step 4 Introductory Training Presentation has been developed by the E6(R3) Expert Working Group.
The ICH E6(R3) Guideline reaches Step 4 of the ICH Process
The ICH E6(R3) “Good Clinical Practice” Guideline reached Step 4 of the ICH Process on 6 January 2025.